Atlas Trials

The Optimal Timing of a Second Autologous Peripheral Blood Stem Cell Transplantation in Patients (<61 Years) With Multiple Myeloma

Clinical trial NCT00207805 · COMPLETED

Trial details

NCT number
NCT00207805
Sponsor
Centre National de Greffe de Moelle Osseuse
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2003-05-01
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.